OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
XTIA$1.7859

XTI Aerospace Inc

Aerospace & DefenseVerified

XTI operates with a cash balance of $16.7 million and a market cap of $68.5 million, yielding a liquidity ratio of 94% (cash-to-market cap). The company's enterprise value to revenue ratio of 2.68 is below the median for aerospace firms, reflecting its current unprofitability and limited scale. With a debt-to-equity ratio of 0.47, XTI maintains a conservative capital structure, but its negative operating cash flow of -$36.6 million raises concerns about long-term liquidity sustainability. The company reported a net loss of $68.8 million on $22.5 million in revenue, resulting in a negative return on equity of -388 basis points. These results fall significantly below the industry median for EBITDA margins and operating margins, indicating operational inefficiencies and pricing pressures in the early-stage eVTOL market. The negative net income combined with high R&D expenses typical of aerospace innovation suggests the company is in a pre-profitability phase. XTI's revenue is concentrated in a single product line (eVTOL aircraft development) with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to regulatory delays, certification risks, and market adoption uncertainties in the urban air mobility sector. The company has not provided segment-specific revenue breakdowns in its disclosures, limiting visibility into potential growth drivers. Looking ahead, XTI's revenue is expected to remain flat in the current fiscal year but could see meaningful growth in FY+1 if it secures commercial orders for its eVTOL aircraft. The company's capital expenditure of -$215,000 in the latest period suggests minimal near-term CAPEX requirements, but significant investment will be needed to scale production and meet certification milestones. Analysts have assigned a mean price target of $5.00, implying 181% upside from current levels, though the single "buy" rating reflects limited institutional conviction. The risk assessment identifies low immediate liquidity and dilution risks, but the company's negative cash flow and limited cash reserves create medium-term liquidity risk if it fails to secure additional financing. No dilution flags were detected in filings, but the company's low cash balance and negative operating performance suggest potential future dilution through equity raises. The absence of debt covenant risks is offset by the high operational risk inherent in aerospace R&D projects. Recent filings show XTI is progressing with its eVTOL prototype development but has not yet achieved commercial sales. Management has emphasized regulatory certification as a key milestone, with no material adverse events reported in the latest disclosures. The company's focus on urban air mobility aligns with industry trends but faces competition from more capitalized players in the eVTOL space.

30-day price · XTIA+0.00 (+0.0%)
Low$1.82High$2.02Close$1.90As of4 May, 00:00 UTC
Profile
CompanyXTI Aerospace Inc
TickerXTIA.O
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryAerospace & Defense
AI analysis

Business. XTI Aerospace Inc designs and develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility applications.

Classification. XTI is classified in the Industrials sector under Aerospace & Defense with 92% confidence based on verified market data.

XTI operates with a cash balance of $16.7 million and a market cap of $68.5 million, yielding a liquidity ratio of 94% (cash-to-market cap). The company's enterprise value to revenue ratio of 2.68 is below the median for aerospace firms, reflecting its current unprofitability and limited scale. With a debt-to-equity ratio of 0.47, XTI maintains a conservative capital structure, but its negative operating cash flow of -$36.6 million raises concerns about long-term liquidity sustainability. The company reported a net loss of $68.8 million on $22.5 million in revenue, resulting in a negative return on equity of -388 basis points. These results fall significantly below the industry median for EBITDA margins and operating margins, indicating operational inefficiencies and pricing pressures in the early-stage eVTOL market. The negative net income combined with high R&D expenses typical of aerospace innovation suggests the company is in a pre-profitability phase. XTI's revenue is concentrated in a single product line (eVTOL aircraft development) with no disclosed geographic diversification. This lack of segment or geographic diversification increases exposure to regulatory delays, certification risks, and market adoption uncertainties in the urban air mobility sector. The company has not provided segment-specific revenue breakdowns in its disclosures, limiting visibility into potential growth drivers. Looking ahead, XTI's revenue is expected to remain flat in the current fiscal year but could see meaningful growth in FY+1 if it secures commercial orders for its eVTOL aircraft. The company's capital expenditure of -$215,000 in the latest period suggests minimal near-term CAPEX requirements, but significant investment will be needed to scale production and meet certification milestones. Analysts have assigned a mean price target of $5.00, implying 181% upside from current levels, though the single "buy" rating reflects limited institutional conviction. The risk assessment identifies low immediate liquidity and dilution risks, but the company's negative cash flow and limited cash reserves create medium-term liquidity risk if it fails to secure additional financing. No dilution flags were detected in filings, but the company's low cash balance and negative operating performance suggest potential future dilution through equity raises. The absence of debt covenant risks is offset by the high operational risk inherent in aerospace R&D projects. Recent filings show XTI is progressing with its eVTOL prototype development but has not yet achieved commercial sales. Management has emphasized regulatory certification as a key milestone, with no material adverse events reported in the latest disclosures. The company's focus on urban air mobility aligns with industry trends but faces competition from more capitalized players in the eVTOL space.
Key takeaways
  • XTI operates with $16.7 million in cash but generates negative operating cash flow, requiring external financing to sustain operations.
  • The company's EV/revenue multiple of 2.68 is significantly below industry medians, reflecting its pre-commercial stage and unprofitability.
  • Revenue is entirely concentrated in eVTOL development with no geographic diversification, increasing exposure to regulatory and market adoption risks.
  • Analysts project $5.00 price target (181% upside) but have assigned only one "buy" rating, indicating limited institutional confidence.
  • No immediate dilution risks are flagged, but the company's negative cash flow and limited cash reserves suggest potential future equity raises.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$22.5M
Gross profit
Operating income
Net income-$68.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$36.6M
CapEx-$215.0k
Free cash flow
Total assets
Total liabilities$60.8M
Total equity$17.7M
Cash & equivalents$16.7M
Long-term debt$8.4M
Valuation
Market price$1.78
Market cap$68.5M
Enterprise value$60.2M
P/E
Reported non-GAAP P/E
EV/Revenue2.7
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash$8.3M
Current ratio
Debt/Equity0.5
ROA
ROE-3.9%
Cash conversion53.0%
CapEx/Revenue-1.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Aerospace & Defense · cohort 184 companies
MetricXTIAActivity
Op margin6.6% medp25 -6.7% · p75 13.4%
Net margin-305.7%4.7% medp25 -6.0% · p75 11.0%bottom quartile
Gross margin28.0% medp25 16.8% · p75 46.8%
R&D / revenue4.1% medp25 4.1% · p75 4.1%
CapEx / revenue-1.0%-6.7% medp25 -17.5% · p75 -3.2%top quartile
Debt / equity47.0%16.5% medp25 3.2% · p75 44.9%top quartile
Observations
IR observations
Mean price target5.00 USD
Median price target5.00 USD
High price target5.00 USD
Low price target5.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.58 USD
Last actual EPS-4.24 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 15:46 UTC#f7e01736
Market quoteclose USD 1.81 · shares 0.04B diluted
no public URL
2026-05-16 15:48 UTC#5552f22d
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 02:13 UTCJob: e1c99698